公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2010 | High-mobility group box 1-mediated matrix metalloproteinase-9 expression in non-small cell lung cancer contributes to tumor cell invasiveness | Liu P.-L.; Tsai J.-R.; Hwang J.-J.; Chou S.-H.; Cheng Y.-J.; Lin F.-Y.; YUH-LIEN CHEN ; Hung C.-Y.; Chen W.-C.; Chen Y.-H.; Chong I.-W. | American Journal of Respiratory Cell and Molecular Biology | 87 | 82 | |
2008 | In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan | Liu J.-W.; Wang L.-S.; Cheng Y.-J.; Hsu G.-J.; Lu P.-L.; Liu Y.-C.; Chen C.-M.; Lee C.-M.; Sun W.; Jang T.-N.; Chiang P.-C.; Chuang Y.-C.; Lin H.-C.; Shi Z.-Y.; HSIANG-CHI KUNG ; Huang C.-H.; Tsao S.-M.; Lu C.-T.; Liao C.-H.; PO-REN HSUEH | International Journal of Antimicrobial Agents | 16 | 17 | |
2008 | In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan determined by the broth microdilution and disk diffusion methods | Liao C.-H.; HSIANG-CHI KUNG ; Hsu G.-J.; Lu P.-L.; Liu Y.-C.; Chen C.-M.; Lee C.-M.; Sun W.; Jang T.-N.; Chiang P.-C.; Cheng Y.-J.; Lin H.-C.; Shi Z.-Y.; Wang L.-S.; Chuang Y.-C.; Tsao S.-M.; Lu C.-T.; Liu J.-W.; Huang C.-H.; PO-REN HSUEH | International Journal of Antimicrobial Agents | 16 | 13 | |
2017 | Inhibition of Epstein-Barr virus reactivation by the flavonoid apigenin | Wu C.-C.; Fang C.-Y.; Cheng Y.-J.; Hsu H.-Y.; Chou S.-P.; Huang S.-Y.; CHING-HWA TSAI ; Chen J.-Y. | Journal of Biomedical Science | 44 | 35 | |
2013 | Intratypic variants of human papillomavirus type 16 and risk of cervical Neoplasia in Taiwan | Chang Y.-J.; Chen H.-C.; Pan M.-H.; Lee B.-H.; You S.-L.; Lin C.-Y.; Chou Y.-C.; CHANG-YAO HSIEH ; Cheng Y.-J.; Liaw K.-L.; Hsing A.W.; Schiffman M.; Chen C.-J. | Journal of Medical Virology | 18 | 16 | |
2013 | Lc3 over-expression improves survival and attenuates lung injury through increasing autophagosomal clearance in septic mice | Lo S.; Yuan S.-S.F.; Hsu C.; Cheng Y.-J.; Chang Y.-F.; Hsueh H.-W.; PO-HUANG LEE ; Hsieh Y.-C. | Annals of Surgery | 100 | 92 | |
2015 | Lrrk regulates the dynamic profile of dendritic Golgi outposts through the golgin Lava lamp | CHIN-HSIEN LIN ; Li H.; Lee Y.-N.; Cheng Y.-J.; RUEY-MEEI WU ; Chien C.-T. | Journal of Cell Biology | 41 | 37 | |
2016 | Luteolin inhibits Epstein-Barr virus lytic reactivation by repressing the promoter activities of immediate-early genes | Wu C.-C.; Fang C.-Y.; Hsu H.-Y.; Chen Y.-J.; Chou S.-P.; Huang S.-Y.; Cheng Y.-J.; Lin S.-F.; Chang Y.; CHING-HWA TSAI ; Chen J.-Y. | Antiviral Research | 46 | 37 | |
2013 | MiR-520h-mediated FOXC2 regulation is critical for inhibition of lung cancer progression by resveratrol | Yu Y.-H.; Chen H.-A.; Chen P.-S.; Cheng Y.-J.; Hsu W.-H.; Chang Y.-W.; Chen Y.-H.; Jan Y.; Hsiao M.; Chang T.-Y.; Liu Y.-H.; YUNG-MING JENG ; Wu C.-H.; Huang M.-T.; Su Y.-H.; Hung M.-C.; Chien M.-H.; Chen C.-Y.; Kuo M.-L.; Su J.-L. | Oncogene | 121 | 105 | |
2008 | Nationwide surveillance in Taiwan of the in-vitro activity of tigecycline against clinical isolates of extended-spectrum β-lactamase-producing Enterobacteriaceae | Lu C.-T.; Chuang Y.-C.; Sun W.; Liu Y.-C.; Cheng Y.-J.; Lu P.-L.; Chen C.-M.; Hsu G.-J.; Jang T.-N.; Lee C.-M.; Chiang P.-C.; Shi Z.-Y.; Wang L.-S.; HSIANG-CHI KUNG ; Lin H.-C.; Liao C.-H.; Liu J.-W.; Huang C.-H.; Tsao S.-M.; PO-REN HSUEH | International Journal of Antimicrobial Agents | 10 | 10 | |
2008 | Nationwide surveillance in Taiwan of the in-vitro activity of tigecycline against clinical isolates of Gram-positive cocci | Tsao S.-M.; Lin H.-C.; Lee C.-M.; Hsu G.-J.; Chen C.-M.; Sun W.; Liu Y.-C.; Jang T.-N.; Cheng Y.-J.; Lu P.-L.; Chiang P.-C.; Wang L.-S.; HSIANG-CHI KUNG ; Chuang Y.-C.; Shi Z.-Y.; Liu J.-W.; Huang C.-H.; Lu C.-T.; Liao C.-H.; PO-REN HSUEH | International Journal of Antimicrobial Agents | 6 | 6 | |
2001 | Occupational exposure to wood, formaldehyde, and solvents and risk of nasopharyngeal carcinoma | Hildesheim A.; Dosemeci M.; CHANG-CHUAN CHAN ; Chen C.-J.; Cheng Y.-J.; Hsu M.-M.; Chen I.-H.; Mittl B.F.; Sun B.; Levine P.H.; Chen J.-Y.; Brinton L.A.; Yang C.-S. | Cancer Epidemiology Biomarkers and Prevention | 139 | 107 | |
2020 | Plasma-activated medium as adjuvant therapy for lung cancer with malignant pleural effusion | Cheng Y.-J.; CHING-KAI LIN ; Chen C.-Y.; Chien P.-C.; Chuan H.-H.; CHAO-CHI HO ; Cheng Y.-C. | Scientific Reports | 7 | 6 | |
2011 | Prognostic utility of anti-EBV antibody testing for defining NPC risk among individuals from high-risk NPC families | Yu K.J.; Hsu W.-L.; Pfeiffer R.M.; CHUN-JU CHIANG ; CHENG-PING WANG ; PEI-JEN LOU ; Cheng Y.-J.; Gravitt P.; Diehl S.R.; Goldstein A.M.; Chen C.-J.; Hildesheim A. | Clinical Cancer Research | 52 | 49 | |
2014 | Reply | Hung M.-H.; Cheng Y.-J.; JIN-SHING CHEN | Annals of Thoracic Surgery | 0 | 0 | |
2016 | Site-controlled crystalline growth of InN on GaN substrate and its photoluminscence | Kuo C.-T; Hsu L.-H; Lai Y.-Y; Kuo H.-C; CHIEN-CHUNG LIN ; Cheng Y.-J. | 2016 Conference on Lasers and Electro-Optics, CLEO 2016 | 0 | 0 | |
2012 | Trends in susceptibility of vancomycin-resistant Enterococcus faecium to tigecycline, daptomycin, and linezolid and molecular epidemiology of the isolates: Results from the Tigecycline in Vitro Surveillance in Taiwan (TIST) study, 2006 to 2010 | Tsai H.-Y.; Liao C.-H.; Chen Y.-H.; Lu P.-L.; Huang C.-H.; Lu C.-T.; Chuang Y.-C.; Tsao S.-M.; Chen Y.-S.; Liu Y.-C.; Chen W.-Y.; Jang T.-N.; Lin H.-C.; Chen C.-M.; Shi Z.-Y.; SUNG-CHING PAN ; Yang J.-L.; HSIANG-CHI KUNG ; Liu C.-E.; Cheng Y.-J.; Liu J.-W.; Sun W.; Wang L.-S.; Ko W.-C.; Yu K.-W.; Chiang P.-C.; Lee M.-H.; Lee C.-M.; Hsu G.-J.; PO-REN HSUEH | Antimicrobial Agents and Chemotherapy | 20 | 19 | |
2013 | Trends in the antimicrobial susceptibilities and serotypes of Streptococcus pneumoniae: Results from the Tigecycline in Vitro Surveillance in Taiwan (TIST) study, 2006-2010 | Tsai H.-Y.; Chen Y.-H.; Liao C.-H.; Lu P.-L.; Huang C.-H.; Lu C.-T.; Chuang Y.-C.; Tsao S.-M.; Chen Y.-S.; Liu Y.-C.; Chen W.-Y.; Jang T.-N.; Lin H.-C.; Chen C.-M.; Shi Z.-Y.; SUNG-CHING PAN ; Yang J.-L.; HSIANG-CHI KUNG ; Liu C.-E.; Cheng Y.-J.; Liu J.-W.; Sun W.; Wang L.-S.; Ko W.-C.; Yu K.-W.; Chiang P.-C.; Lee M.-H.; Lee C.-M.; Hsu G.-J.; PO-REN HSUEH | International Journal of Antimicrobial Agents | 11 | 11 | |
2012 | Trends in the susceptibility of clinically important resistant bacteria to tigecycline: Results from the tigecycline In Vitro surveillance in Taiwan study, 2006 to 2010 | Chen Y.-H.; Lu P.-L.; Huang C.-H.; Liao C.-H.; Lu C.-T.; Chuang Y.-C.; Tsao S.-M.; Chen Y.-S.; Liu Y.-C.; Chen W.-Y.; Jang T.-N.; Lin H.-C.; Chen C.-M.; Shi Z.-Y.; SUNG-CHING PAN ; Yang J.-L.; HSIANG-CHI KUNG ; Liu C.-E.; Cheng Y.-J.; Liu J.-W.; Sun W.; Wang L.-S.; Ko W.-C.; Yu K.-W.; Chiang P.-C.; Lee M.-H.; Lee C.-M.; Hsu G.-J.; PO-REN HSUEH | Antimicrobial Agents and Chemotherapy | 39 | 35 | |
2014 | Trends in the susceptibility of methicillin-resistant Staphylococcus aureus to nine antimicrobial agents, including ceftobiprole, nemonoxacin, and tyrothricin: Results from the Tigecycline in Vitro Surveillance in Taiwan (TIST) study, 2006-2010 | Chen Y.-H.; Liu C.-Y.; Ko W.-C.; Liao C.-H.; Lu P.-L.; Huang C.-H.; Lu C.-T.; Chuang Y.-C.; Tsao S.-M.; Chen Y.-S.; Liu Y.-C.; Chen W.-Y.; Jang T.-N.; Lin H.-C.; Chen C.-M.; Shi Z.-Y.; SUNG-CHING PAN ; Yang J.-L.; HSIANG-CHI KUNG ; Liu C.-E.; Cheng Y.-J.; Liu J.-W.; Sun W.; Wang L.-S.; Yu K.-W.; Chiang P.-C.; Lee M.-H.; Lee C.-M.; Hsu G.-J.; PO-REN HSUEH | European Journal of Clinical Microbiology and Infectious Diseases | 22 | 19 | |